427 related articles for article (PubMed ID: 2117053)
1. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
Lamensdorf I; Youdim MB; Finberg JP
J Neurochem; 1996 Oct; 67(4):1532-9. PubMed ID: 8858937
[TBL] [Abstract][Full Text] [Related]
3. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism.
Brannan T; Prikhojan A; Martínez-Tica J; Yahr MD
J Neural Transm Park Dis Dement Sect; 1995; 10(2-3):79-89. PubMed ID: 9620056
[TBL] [Abstract][Full Text] [Related]
4. Selective monoamine oxidase subtype inhibition and striatal extracellular dopamine in the guinea-pig.
Ilani T; Lamensdorf I; Finberg JP
Br J Pharmacol; 2000 Aug; 130(8):1992-8. PubMed ID: 10952692
[TBL] [Abstract][Full Text] [Related]
5. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
Kato T; Dong B; Ishii K; Kinemuchi H
J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
[TBL] [Abstract][Full Text] [Related]
6. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: I. Studies using veratrine and ouabain.
Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
J Neurochem; 1990 Jun; 54(6):1834-43. PubMed ID: 2338544
[TBL] [Abstract][Full Text] [Related]
7. Guinea pig striatum as a model of human dopamine deamination: the role of monoamine oxidase isozyme ratio, localization, and affinity for substrate in synaptic dopamine metabolism.
Azzaro AJ; King J; Kotzuk J; Schoepp DD; Frost J; Schochet S
J Neurochem; 1985 Sep; 45(3):949-56. PubMed ID: 3928811
[TBL] [Abstract][Full Text] [Related]
8. Influence of selective inhibition of monoamine oxidase A or B on striatal metabolism of L-DOPA in hemiparkinsonian rats.
Finberg JP; Wang J; Goldstein DS; Kopin IJ; Bankiewicz KS
J Neurochem; 1995 Sep; 65(3):1213-20. PubMed ID: 7643100
[TBL] [Abstract][Full Text] [Related]
9. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
Sivam SP
Neuropeptides; 1993 Jul; 25(1):35-45. PubMed ID: 7692341
[TBL] [Abstract][Full Text] [Related]
10. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
[TBL] [Abstract][Full Text] [Related]
11. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
[TBL] [Abstract][Full Text] [Related]
12. Monoamine oxidase inhibition causes a long-term prolongation of the dopamine-induced responses in rat midbrain dopaminergic cells.
Mercuri NB; Scarponi M; Bonci A; Siniscalchi A; Bernardi G
J Neurosci; 1997 Apr; 17(7):2267-72. PubMed ID: 9065488
[TBL] [Abstract][Full Text] [Related]
13. Release of endogenous dopamine from rat isolated striatum: effect of clorgyline and (-)-deprenyl.
Hársing LG; Vizi ES
Br J Pharmacol; 1984 Nov; 83(3):741-9. PubMed ID: 6439273
[TBL] [Abstract][Full Text] [Related]
14. Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.
Lamensdorf I; Porat S; Simantov R; Finberg JP
Br J Pharmacol; 1999 Feb; 126(4):997-1002. PubMed ID: 10193780
[TBL] [Abstract][Full Text] [Related]
15. In vivo studies on the effect of monoamine oxidase inhibitors on dopamine and serotonin metabolism in rat brain areas.
Clement HW; Grote C; Wesemann W
J Neural Transm Suppl; 1990; 32():85-8. PubMed ID: 2128514
[No Abstract] [Full Text] [Related]
16. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
17. Deamination of norepinephrine, dopamine, and serotonin by type A monoamine oxidase in discrete regions of the rat brain and inhibition by RS-8359.
Kumagae Y; Matsui Y; Iwata N
Jpn J Pharmacol; 1991 Jan; 55(1):121-8. PubMed ID: 1904113
[TBL] [Abstract][Full Text] [Related]
18. Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain.
Tekes K; Tóthfalusi L; Gaál J; Magyar K
Pol J Pharmacol Pharm; 1988; 40(6):653-8. PubMed ID: 3152003
[TBL] [Abstract][Full Text] [Related]
19. Oxygen inhalation enhances striatal dopamine metabolism and monoamineoxidase enzyme inhibition prevents it: a microdialysis study.
Adachi YU; Watanabe K; Higuchi H; Satoh T; Vizi ES
Eur J Pharmacol; 2001 Jun; 422(1-3):61-8. PubMed ID: 11430914
[TBL] [Abstract][Full Text] [Related]
20. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
